The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport

Kidney International

Volumn 86, Issue 1, 2014, Pages 118-126

  Gildea, John J ^a   Shah, Ishan T ^a   Van Sciver, Robert E ^a   Israel, Jonathan A ^a   Enzensperger, Christoph ^b   Mcgrath, Helen E ^a   Jose, Pedro A ^c   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

calcium; cell signaling; cyclic AMP; kidney; Na transport; renal proximal tubule cell

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR D5; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; LE 300; LE PM 436; PHOSPHOLIPASE C; SKF 83822; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN 3; UNCLASSIFIED DRUG; 3-ALLYL-6-CHLORO-7,8-DIHYDROXY-1-(3-METHYLPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE; BENZAZEPINE DERIVATIVE; DOPAMINE 5 RECEPTOR; SODIUM;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; KIDNEY PROXIMAL TUBULE; MICROVILLUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SECOND MESSENGER; SODIUM TRANSPORT; URINARY EXCRETION; ACTIVE TRANSPORT; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM;

BENZAZEPINES; BIOLOGICAL TRANSPORT, ACTIVE; CELLS, CULTURED; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FENOLDOPAM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; MODELS, BIOLOGICAL; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RNA, SMALL INTERFERING; SECOND MESSENGER SYSTEMS; SODIUM;

EID: 84903754245     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.5     Document Type: Article

References (50)

1. Siragy HM, Felder RA, Howell NL et al. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 1989; 257: F469-F477.
2. Pelayo JC, Fildes RD, Eisner GM et al. Effects of dopamine blockade on renal sodium excretion. Am J Physiol 1983; 245: F247-F253. (Pubitemid 13031342)
3. Jose PA, Eisner GM, Felder RA. Dopamine and the kidney: A role in hypertension? Curr Opin Nephrol Hypertens 2003; 12: 189-194.
4. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228: 134-142. (Pubitemid 36187919)
5. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998; 80: 149-182. (Pubitemid 28498226)
6. Zhang MZ, Yao B, Wang S et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121: 2845-2854.
7. Sunahara RK, Guan HC, Odowd BF et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614-619. (Pubitemid 21912283)
8. Kimura K, White BH, Sidhu A. Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o). J Biol Chem 1995; 270: 14672-14678.
9. Corvol JC, Studler JM, Schonn JS et al. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 2001; 76: 1585-1588. (Pubitemid 32198262)
10. Sidhu A, Kimura K, Uh M et al. Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J Neurochem 1998; 70: 2459-2467. (Pubitemid 28252371)
11. Zheng S, Yu P, Zeng C et al. Galpha12-And Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41: 604-610. (Pubitemid 36314639)
12. Jin LQ, Wang HY, Friedman E. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J Neurochem 2001; 78: 981-990. (Pubitemid 32823147)
13. Jin LQ, Goswami S, Cai G et al. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 2003; 85: 378-386. (Pubitemid 36438333)
14. Sahu A, Tyeryar KR, Vongtau HO et al. D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 2009; 75: 447-453.
15. Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther 2010; 128: 37-60.
16. Ciliax BJ, Nash N, Heilman C et al. Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 2000; 37: 125-145.
17. Zeng C, Armando I, Luo Y et al. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: Studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294: H551-H569. (Pubitemid 351253262)
18. Felder CC, Jose PA, Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 1989; 248: 171-175. (Pubitemid 19063485)
19. Vyas SJ, Jadhav AL, Eichberg J et al. Dopamine receptor-mediated activation of phospholipase C is associated with natriuresis during high salt intake. Am J Physiol 1992; 262: F494-F498.
20. Gildea JJ, Wang X, Jose PA et al. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 2008; 51: 360-366. (Pubitemid 351159951)
21. Albrecht FE, Drago J, Felder RA et al. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97: 2283-2288.
22. Hollon TR, Bek MJ, Lachowicz JE et al. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22: 10801-10810. (Pubitemid 36005154)
23. Yang Z, Asico LD, Yu P et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290: R96-R104.
24. Yang Z, Sibley DR, Jose PA. D5 dopamine receptor knockout mice and hypertension. J Recept Signal Transduct Res 2004; 24: 149-164. (Pubitemid 39332215)
25. Yang Z, Asico LD, Yu P et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol 2006; 290: R96-R104.
26. Zeng C, Yang Z, Asico LD et al. Regulation of blood pressure by D5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 2007; 5: 241-248. (Pubitemid 47180855)
27. Gildea JJ, Shah I, Weiss R et al. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension 2010; 56: 505-511.
28. Mohr P, Decker M, Enzensperger C et al. Dopamine/serotonin receptor ligands. 12(1): SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist. J Med Chem 2006; 49: 2110-2116.
29. Yu P, Yang Z, Jones JE et al. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 2004; 66: 2167-2180. (Pubitemid 41115280)
30. Amenta F, Ricci A, Tayebati SK et al. The peripheral dopaminergic system: Morphological analysis, functional and clinical applications. Ital J Anat Embryol 2002; 107: 145-167.
31. Odowd BF, Ji X, Alijaniaram M et al. Dopamine receptor oligomerization visualized in living cells. J Biol Chem 2005; 280: 37225-37235. (Pubitemid 41587807)
32. Weinbaum S, Duan Y, Satlin LM et al. Mechanotransduction in the renal tubule. Am J Physiol Renal Physiol 2010; 299: F1220-F1236.
33. Gildea JJ, Israel JA, Johnson AK et al. Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension 2009; 54: 1070-1076.
34. Gildea JJ, Lahiff DT, Van Sciver RE et al. A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: The virtual renal biopsy. Clin Chim Acta 2013; 421: 236-242.
35. Gildea JJ, Wang X, Shah N et al. Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 2012; 60: 396-403.
36. Yu P, Han W, Villar VA et al. Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk. Free Radic Biol Med 2011; 50: 832-840.
37. Gomes P, Soares-da-Silva P. Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity. Am J Physiol Renal Physiol 2002; 282: F1084-F1096. (Pubitemid 34654474)
38. Efendiev R, Budu CE, Cinelli AR et al. Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 2003; 278: 28719-28726. (Pubitemid 36935779)
39. Wang X, Luo Y, Escano CS et al. Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension 2010; 55: 1431-1437.
40. Armando I, Villar VA, Jose PA. Dopamine and renal function and blood pressure regulation. Compr Physiol 2011; 1: 1075-1117.
41. Gildea JJ. Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance. Curr Opin Nephrol Hypertens 2009; 18: 28-32.
42. Felder RA, Sanada H, Xu J et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99: 3872-3877. (Pubitemid 34252198)
43. Sanada H, Jose PA, Hazen-Martin D et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33: 1036-1042. (Pubitemid 29186405)
44. Yu P, Yang Z, Jones JE et al. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 2004; 66: 2167-2180. (Pubitemid 41115280)
45. Xu J, Li XX, Albrecht FE et al. Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension 2000; 36: 395-399.
46. OConnell DP, Botkin SJ, Ramos SI et al. Localization of dopamine D1A receptor protein in rat kidneys. Am J Physiol 1995; 268: F1185-F1197.
47. Brismar H, Asghar M, Carey RM et al. Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci USA 1998; 95: 5573-5578. (Pubitemid 28224136)
48. Violin JD, Zhang J, Tsien RY et al. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol 2003; 161: 899-909. (Pubitemid 36718423)
49. Violin JD, DiPilato LM, Yildirim N et al. Beta2-Adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 2008; 283: 2949-2961.
50. Honegger KJ, Capuano P, Winter C et al. Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein directly activated by cAMP (EPAC). Proc Natl Acad Sci USA 2006; 103: 803-808.